Ingenuity TF PET/CT – Leverages Philips' Astonish TF technology for enhanced image contrast, resolution, and quality. Features Philips' proprietary xPand5 quantification tools to assist in measuring and monitoring disease progression. These technologies join CT advances, such as iPatient, iDose⁴and metal artifact reduction for implants (O-MAR), to drive confidence and consistency through personalized patient centric workflow.
IntelliSpace Portal 9.0 – IntelliSpace Portal 9.0 – The latest edition of Philips' comprehensive, advanced visualization and analysis platform offers quantitative tumor tracking and treatment response tools with a streamlined workflow for follow‐up and analysis in oncology cases. IntelliSpace Portal 9.0 provides enterprise‐wide access to a comprehensive suite of Molecular Imaging processing and review applications for general Nuclear Medicine, SPECT, SPECT/CT and PET/CT.
SPECT Solutions – To fulfill the need for clinically dependable SPECT systems, Philips provides cost-efficient cardiac and general-purpose SPECT solutions that maximize the return on investment.
Innovation Talks
Ad Statistics
Times Displayed: 113242
Times Visited: 6741 MIT labs, experts in Multi-Vendor component level repair of: MRI Coils, RF amplifiers, Gradient Amplifiers Contrast Media Injectors. System repairs, sub-assembly repairs, component level repairs, refurbish/calibrate. info@mitlabsusa.com/+1 (305) 470-8013
This year, Philips will host a number of talks and presentations at its booth (#657) at SNMMI. In addition, Philips' academic partners will present 19 scientific presentations and posters demonstrating the value Philips' digital PET/CT system is bringing to molecular imaging – advancing knowledge and application using features such as lesion detection and quantitative imaging.
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips' health technology portfolio generated 2016 sales of EUR 17.4 billion and employs approximately 70,000 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com\newscenter.
Back to HCB News
